4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine has been researched along with Amnesia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carli, M; Dekeyne, A; Di Cara, B; Gobert, A; Jaffard, R; Lestage, P; Meneses, A; Millan, MJ; Mocaer, E; Peglion, JL; Porsolt, R; Rivet, JM; Roux, S | 1 |
1 other study(ies) available for 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine and Amnesia
Article | Year |
---|---|
The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acetylcholine; Aging; Amnesia; Animals; Dialysis; Discrimination Learning; Drug Interactions; Hippocampus; Male; Maze Learning; Memory; Mice; Mice, Inbred C57BL; Piperazines; Prefrontal Cortex; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Recognition, Psychology; Scopolamine; Serotonin Receptor Agonists; Spatial Behavior | 2004 |